Material Event - Form 8-K

Item 1.01 Entry into a Material Definitive Agreement.

On April 26^th 2024 Regen Biopharma, Inc. ( the "Company") entered into an agreement with Value Quest, Inc. ( "Value Quest Agreement"). Pursuant to the Value Quest Agreement Value Quest Inc. shall provide social media consulting services to the Company for a period of one year commencing on April 26, 2024.

Consideration to be paid to Value Quest, Inc. pursuant to the Value Quest Agreement shall be 20,068 shares of the Series A Preferred stock of the Company.

The foregoing description of the abovementioned Value Quest Agreement is not complete and is qualified in its entirety by reference to the text of the abovementioned agreement which is attached to this Current Report on Form 8-K as Exhibit 10.1 and incorporated in this Item 1.01 by reference.

Item 8.01 Other Events.

On April 26, 2024 the Company and BST Partners ( Sublessor) agreed to amend that sublease agreement ("Sublease Agreement") entered into between the parties as follows:

The Company agreed that in addition to the base rent of $5,000 per month to be paid by the Company to Sublessor the Company shall also reimburse Sublessor for any and all shared expenses as such term is defined within the Sublease Agreement.

On January 13, 2022 the Company entered into the Sublease Agreement whereby the Company would sublet office space located at 4700 Spring Street, Suite 304, La Mesa, California 91942 from the Sublessor on a month to month basis for $5,000 per month beginning January 14, 2022.

BST Partners is controlled by David Koos who serves as the sole officer and director of Regen Biopharma, Inc.

The foregoing description of the abovementioned amendment and Sublease Agreement are not complete and are qualified in their entirety by reference to the text of the abovementioned amendment and Sublease Agreement which are attached to this Current Report on Form 8-K as Exhibit 10.2 and 10.3 and incorporated in this Item 8.01 by reference.